June 14, 2013

Arco Health, Inc., makers of Diet-Burst gum, announced last week new packaging designs for its dietary supplement gum, as well as new nicotine replacement products available in July.

April 29, 2013

Johnson & Johnson chairman and CEO Alex Gorsky last week told shareholders that its consumer healthcare business would reclaim its prominence in the U.S. marketplace at the company's annual shareholder meeting. But OTC growth will be greatest outside of the United States.

April 1, 2013

GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

February 4, 2013

Perrigo chairman, CEO and president Joe Papa shared with analysts that private label OTCs are trending strong and that growth will be sustained going forward with the number of projected Rx-to-OTCs on the horizon.

January 22, 2013

Perrigo announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor), comparable to GlaxoSmithKline's Nicorette mini lozenge.

October 10, 2012

Perrigo on Wednesday announced that it has received approval from the Food and Drug Administration for its abbreviated new drug applications to market over-the-counter nicotine polacrilex mini lozenge USP in both 2-mg and 4-mg strengths.

January 25, 2012

Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday.

December 29, 2011

To help its members keep their New Year's resolutions, including weight loss, eating better and quitting smoking, Sam's Club will offer a variety of free in-club health screenings and smoking-cessation consultations.

July 22, 2011

Perrigo on Thursday announced that it has received approval from the Food and Drug Administration to market a cinnamon-flavored, over-the-counter coated nicotine polacrilex gum USP in 2-mg and 4-mg strengths.

April 15, 2011

Duh, winning! Because there are no losers in this. GlaxoSmithKline will be able to funnel its extensive marketing dollars into a stable of poised-to-explode brands, niche marketers can take those brands being sold and breathe fresh marketing life into them and retailers now benefit most of all because a greater portfolio of brands are being marketed with gusto.

January 5, 2011

PITTSBURGH — The Centers for Disease Control and Prevention and the Food and Drug Administration last year initiated programs that will breathe new life into sales of smoking-cessation products. The surgeon general issued a report titled “How Tobacco Smoke Causes Disease,” and the FDA will be mandating that tobacco manufacturers have smoking-is-bad-for-you messages on packaging. 


October 27, 2010

GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific...

September 27, 2010

GlaxoSmithKline Consumer Healthcare is urging the Food and Drug Administration to remove smokeless tobacco products...

August 25, 2010

To help raise awareness around Commit Lozenge, which has been folded into the Nicorette franchise,...

June 6, 2010

GlaxoSmithKline in April announced the launch of its new Nicorette Mini Lozenge, a smaller smoking...

May 16, 2010

The atmosphere this year at the National Association of Chain Drug Stores’ Annual Meeting was...

April 26, 2010

GlaxoSmithKline announced Tuesday the launch of its new Nicorette Mini Lozenge, a smaller smoking-cessation lozenge...

December 13, 2009

GlaxoSmithKline’s “Nicorette makes quitting suck less” campaign is a smart play that ought to continue...

July 5, 2009

First, it’s the first truly “new” product to enter the smoking cessation space in...